Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

New B&M CEO Jegen buys more than half a million pounds worth of shares

(Sharecast News) - B&M European Value Retail sparked on Tuesday after the discount retailer's new chief executive picked up more than half a million pounds worth of shares. Tjeerd Jegen, who took on the role of CEO on Monday, bought 197,900 shares for £523,559.60. The transactions were made between 10 and 13 June.

Russ Mould, investment director at AJ Bell, said: "B&M's new chief executive Tjeerd Jegen has aligned himself with shareholders' interests after spending more than half a million of pounds on shares in the value retailer.

"It sends a positive signal to the market that he's serious about turning the business around. Failure to do so would hurt his wallet as well as his reputation.

"Investors often take director share purchases to be a positive sign. Many large companies require CEOs to buy a minimum value of shares within a certain period after taking the top job, so they have skin in the game.

"B&M is no longer a FTSE 100 member so Jegen may not be forced to buy stock, yet the fact he's already done so in his first week has been taken positively by the market."

At 1010 BST, the shares were up 2.6% at 262.60p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.